biosimilar patent challenges

Explore the complexities surrounding biosimilar patent challenges, including the latest legal developments and case law that impact the pharmaceutical industry. Visitors will find in-depth articles, expert interviews with attorneys specializing in intellectual property law, and comprehensive resources that illuminate the intricacies of patent litigation related to biosimilars. Stay informed about the evolving landscape of patent law and its implications for biosimilar competition and market access.

Legal Solutions: Enhance Biotech Dispute Wins for Advocates

How can lawyers resolve patent disputes in biotech using emerging litigation strategies?

Business Development, Business Law, Business/Corporate, Corporate Law, Court Procedures, Intellectual Property, Legal Ethics, Technology Law / Jack Gilbert

Biotech patent disputes can often be resolved through early validity and infringement analysis, targeted PTAB challenges, and strategic settlement—frequently reducing time and cost compared with full trial. As biologics, diagnostics, and gene-editing patents become more complex, parties increasingly use coordinated forum selection, expert-driven claim construction, and narrowed damages theories to improve outcomes. This article explains […]

How can lawyers resolve patent disputes in biotech using emerging litigation strategies? Read More »

Patent Disputes in Biotech: Emerging Trends and Litigation Strategies

Biotech patent disputes now most often turn on three issues: enablement/written description, priority/ownership, and global enforcement of CRISPR, AI-driven inventions, and biologics. Parties increasingly pair PTAB tactics with district-court litigation and factor in regulatory exclusivities. This article covers emerging trends and practical biotech litigation strategies for validity, infringement, and cross-border risk. Legal professionals frequently ask,